Basic Information
Pelgraz Solution for Injection in pre-filled syringe 6mg/0.6mL
INJECTION, SOLUTION
Regulatory Information
SIN16249P
June 24, 2021
Prescription Only
Therapeutic
SUBCUTANEOUS
August 10, 2023
June 3, 2025
XL03AA13
Company Information
ACCORD HEALTHCARE PRIVATE LIMITED
ACCORD HEALTHCARE PRIVATE LIMITED
Active Ingredients
Strength: 6 mg/0.6 mL
Detailed Information
Contraindications
**4.3 Contraindications** Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_.
Indication Information
**4.1 Therapeutic indications** Reduction in the duration of neutropenia and the incidence of febrile neutropenia in adult patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes).